Acute ataxia in paediatric emergency departments: a multicentre Italian study.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
08 2019
Historique:
received: 08 05 2018
revised: 20 02 2019
accepted: 21 02 2019
pubmed: 6 4 2019
medline: 25 2 2020
entrez: 6 4 2019
Statut: ppublish

Résumé

To evaluate the causes and management of acute ataxia (AA) in the paediatric emergency setting and to identify clinical features predictive of an underlying clinically urgent neurological pathology (CUNP). This is a retrospective medical chart analysis of children (1-18 years) attending to 11 paediatric emergency departments (EDs) for AA in an 8-year period. A logistic regression model was applied to identify clinical risk factors for CUNP. 509 patients (mean age 5.8 years) were included (0.021% of all ED attendances). The most common cause of AA was acute postinfectious cerebellar ataxia (APCA, 33.6%). Brain tumours were the second most common cause (11.2%), followed by migraine-related disorders (9%). Nine out of the 14 variables tested showed an OR >1. Among them, meningeal and focal neurological signs, hyporeflexia and ophthalmoplegia were significantly associated with a higher risk of CUNP (OR=3-7.7, p<0.05). Similarly, the odds of an underlying CUNP were increased by 51% by each day from onset of ataxia (OR=1.5, CI 1.1 to 1.2). Conversely, a history of varicella-zoster virus infection and vertigo resulted in a significantly lower risk of CUNP (OR=0.1 and OR=0.5, respectively; p<0.05). The most frequent cause of AA is APCA, but CUNPs account for over a third of cases. Focal and meningeal signs, hyporeflexia and ophthalmoplegia, as well as longer duration of symptoms, are the most consistent 'red flags' of a severe underlying pathology. Other features with less robust association with CUNP, such as seizures or consciousness impairment, should be seriously taken into account during AA evaluation.

Identifiants

pubmed: 30948362
pii: archdischild-2018-315487
doi: 10.1136/archdischild-2018-315487
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-774

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Giacomo Garone (G)

University Hospital Pediatric Department, Bambino Gesù Children's Hospital IRCCS, University of Rome Tor Vergata, Rome, Italy.

Antonino Reale (A)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Nicola Vanacore (N)

National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy.

Pasquale Parisi (P)

Chair of Pediatrics, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.

Claudia Bondone (C)

Department of Pediatric Emergency, Regina Margherita Pediatric Hospital, Turin, Italy.

Agnese Suppiej (A)

Child Neurology and Clinical Neurophysiology, Department of Woman and Child Health, University of Padua, Padova, Italy.
Department of Medical Sciences, Pediatric Section, University of Ferrara, Ferrara, Italy.

Giacomo Brisca (G)

Pediatric Emergency Department, Giannina Gaslini Children's Hospital, Genoa, Italy.

Lucia Calistri (L)

Pediatric Emergency Unit, Anna Meyer Children's Hospital, Florence, Italy.

Duccio Maria Cordelli (DM)

Child Neurology Unit, University of Bologna, Bologna, Italy.

Salvatore Savasta (S)

Department of Pediatrics, Fondazione Policlinico San Matteo IRCCS, University of Pavia, Pavia, Italy.

Salvatore Grosso (S)

Clinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy.

Fabio Midulla (F)

Pediatric Emergency Unit, Department of Pediatrics, Child Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Raffaele Falsaperla (R)

Unit of Pediatrics and Emergency Pediatrics, AOU Policlinico Vittorio Emanuele, Catania, Italy.

Alberto Verrotti (A)

Department of Pediatrics, University of L'Aquila, L'Aquila, Italy.

Elena Bozzola (E)

Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Cristina Vassia (C)

Department of Pediatric Emergency, Regina Margherita Pediatric Hospital, Turin, Italy.

Liviana Da Dalt (L)

Pediatric Emergency Department, Department of Woman's and Child Health, University of Padova, Padova, Italy.

Rosario Maggiore (R)

Pediatric Emergency Department, Giannina Gaslini Children's Hospital, Genoa, Italy.

Stefano Masi (S)

Pediatric Emergency Unit, Anna Meyer Children's Hospital, Florence, Italy.

Lucia Maltoni (L)

Child Neurology Unit, University of Bologna, Bologna, Italy.

Thomas Foiadelli (T)

Department of Pediatrics, Fondazione Policlinico San Matteo IRCCS, University of Pavia, Pavia, Italy.

Annalisa Rossetti (A)

Clinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy.

Carla Greco (C)

Pediatric Emergency Unit, Department of Pediatrics, Child Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Silvia Marino (S)

Unit of Pediatrics and Emergency Pediatrics, AOU Policlinico Vittorio Emanuele, Catania, Italy.

Claudia Di Paolantonio (C)

Department of Pediatrics, University of L'Aquila, L'Aquila, Italy.

Laura Papetti (L)

Division of Neurology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Antonio Francesco Urbino (AF)

Department of Pediatric Emergency, Regina Margherita Pediatric Hospital, Turin, Italy.

Rossella Rossi (R)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Umberto Raucci (U)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH